Autism Spectrum Disorder (ASD)
Conditions
Keywords
Autism Spectrum Disorder (ASD), Transition program
Brief summary
Clinical trial without drug, randomized: Comparison of a specific and integrative clinical protocol for young adults with autism to usual treatment. It will include both low and high-functioning participants.
Interventions
OTHERIntegrative interventional programme
The active condition includes specialized, multidisciplinary and intensive individual (weekly to monthly) or group interventions (weekly). Only high-functioning subjects will be considered for group interventions.
OTHERAs usual
The control group will follow treatment as usual, consisting in conventional general psychiatrist/psychologist clinical follow-up. The frequency varies between 3-6 months or 15-21 days if worsening of symptoms or comorbid conditions.
Sponsors
Corporacion Parc Tauli
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
A researcher will be masked for group aleatorization (active, group) in order to unbiasedly evaluate outcomes which require subjective assesment of functionality.
Eligibility
Sex/Gender
ALL
Age
18 Years to 21 Years
Healthy volunteers
No
Inclusion criteria
* ASD diagnosis * Previous follow-up by child and adolescent psychiatry department at Corporació Sanitària Parc Taulí (CSPT)
Exclusion criteria
\- Living in a disabled residential setting
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Quality of life. | Baseline, 24 months | The World Health Organization Quality of Life (WHOQOL). Self-administered scale, quantitative. Spanish version. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in: Depressive symptoms | Baseline, 24 months | Beck Depression Inventory-II (BDI-II) . Self-administered scale, quantitative.Spanish version. |
| Change in: Anxiety Symptoms. | Baseline, 24 months | Beck Anxiety Inventory (BAI). Self-administered scale, quantitative.Spanish version. |
| Change in: Obsessive-compulsive symptoms. | Baseline, 24 months | Obsessive-Compulsive Inventory - Revised (OCI-R). Self-administered scale, quantitative. Spanish version. |
| Change in: ASD symptoms evaluated by parents/caregiver. | Baseline, 24 months | Social Responsiveness Scale (SRS). Parents' self-administered scale, quantitative.Spanish version. |
| Change in: Asperger Symptoms. | Baseline, 24 months | Adult Asperger Assessment (AAA). Includes questionnaire (autism spectrum quotient, AQ) and (empathy quotient, EQ). Self-administered scale, quantitative.Spanish version. |
| Change in: Social phobia symptoms. | Baseline, 24 months | Social Phobia Inventory (SPIN). Self-administered scale, quantitative. Spanish version. |
| Change in: Evaluation of support needs. | Baseline, 24 months | Camberwell Assessment of Need, revised (CAN-R). Administered by the professional, qualitative. Spanish version. |
| Change in: Caregiver's burden associated with the disorder. | Baseline, 24 months | The Zarit Burden Interview. Caregiver self-report, quantitative. Spanish version. |
| Change in: Evaluation of the level of autonomy, self-regulation, self-empowerment, self-knowledge. | Baseline, 24 months | The Arc's Self-Determination Scale. Self-administered scale. Spanish version. Quantitative. |
| Change in: ASD symptoms. | Baseline, 24 months | Ritvo Autism Asperger's Diagnostic Scale (RAADS-R). Self-administered scale, quantitative. Spanish- translated version. |
Countries
Spain
Contacts
Primary ContactESTHER VIA, PHD
Backup ContactIsabel Parra, MD
Outcome results
None listed